Apricus Biosciences (APRI)

Add to Watchlists
Create an Alert
2.38 -0.01  -0.42% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
APRI Price Chart
View All Events

APRI Events

Date Type Description
Mar 17 Misc Q4 2013 Apricus Biosciences, Inc. Earnings Conference Call
Mar 17 Earnings Q4 2013 Apricus Biosciences, Inc. Earnings Results. Estimate: -0.06.
Nov 13 Misc Apricus Biosciences Announces Third Quarter 2013 Corporate Update Conference Call
Nov 13 Earnings Apricus Biosciences Announces Third Quarter 2013 Results Release. Estimate: -0.10.
Aug 12 Misc Apricus Biosciences Reports Corporate Update
May 10 Misc Apricus Biosciences Announces First Quarter 2013 Financial Results Conference Call
May 10 Earnings Apricus Biosciences Announces First Quarter 2013 Financial Results Conference Call. Estimate: -0.05.
View All Performance Charts

APRI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Apricus Biosciences is down 17.36% over the last year vs S&P 500 Total Return up 23.54%, Lannett up 215.9%, and Jazz Pharmaceuticals up 148.9%.

Get Quote for
Advertisement

Portfolio Strategies Featuring APRI

Did Apricus Biosciences make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

APRI Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Nevada
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Apricus Biosciences, Inc., is a pharmaceutical company. It develops and commercializes pharmaceutical products that treat large patient populations with operations based in the United States.

Recent Quotes

Symbol Price Chg Chg % Market Cap
APRI 2.38 -0.01 -0.42% 89.35M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.